| Identification | Back Directory | [Name]
Urea, N-[(1S,1aS,6bS)-1a,6b-dihydro-5-[(5,6,7,8-tetrahydro-7-oxo-1,8-naphthyridin-4-yl)oxy]-1H-cyclopropa[b]benzofuran-1-yl]-N'-(2,4,5-trifluorophenyl)- | [CAS]
1643326-82-2 | [Synonyms]
Brimarafenib
BGB-3245(Brimarafenib)
1-[(1S,1aS,6bS)-5-[(7-oxo-6,8-dihydro-5H-1,8-naphthyridin-4-yl)oxy]-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-1-yl]-3-(2,4,5-trifluorophenyl)urea
Urea, N-[(1S,1aS,6bS)-1a,6b-dihydro-5-[(5,6,7,8-tetrahydro-7-oxo-1,8-naphthyridin-4-yl)oxy]-1H-cyclopropa[b]benzofuran-1-yl]-N'-(2,4,5-trifluorophenyl)- | [Molecular Formula]
C24H17F3N4O4 | [MOL File]
1643326-82-2.mol | [Molecular Weight]
482.41 |
| Hazard Information | Back Directory | [Uses]
Brimarafenibum (Brimarafenib) is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor, wtih antineoplastic effect[1]. | [References]
[1] Brimarafenibum (Brimarafenib). WHO Drug Information, Vol. 37, No. 4, 2023. |
|
| Company Name: |
Elucigen bio
|
| Tel: |
13501719342; 13501719342 |
| Website: |
|
|